Trial Details
COMPLETEDBasic Information
| Clinical ID | c3801 |
|---|---|
| Identifier | NCT01514240 |
| Trial Title | Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: D9421-C capsule 3 mg|DRUG: Mesalazine tablets |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Chikushino-shi |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2012-02 |
|---|---|
| Primary Completion Date | 2014-09 |
| Completion Date | 2014-09 |